ClinicalTrials.govpublic full text
T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases
chronic myeloproliferative disorders, leukemia, lymphoma, multiple myeloma and malignant plasma cell neoplasms, myelodysplastic syndromes, precancerous/nonmalignant condition, secondary myelofibrosis, adult leukemia, plasma cell disorders, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 834819
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.